Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03699917 · ClinicalTrials.gov registry record
Goal-directed Fluid Therapy on Complications After Pancreaticoduodenectomy
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 64
- Enrollment target
NCT03699917 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 64 participants.
The verdict
NCT03699917 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
Study Summary
Optimal fluid balance is critical to minimize anastomotic edema in patients undergoing pancreaticoduodenectomy. This study examined the effects of decreased fluid administration on rates of postoperative pancreatic leak and delayed gastric emptying.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2015-01-01 |
| Est. Completion | 2016-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03699917
The ClinicalTrials.gov registry entry for NCT03699917 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03699917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03699917 about?
NCT03699917 is a clinical study titled "Goal-directed Fluid Therapy on Complications After Pancreaticoduodenectomy". Optimal fluid balance is critical to minimize anastomotic edema in patients undergoing pancreaticoduodenectomy. This study examined the effects of decreased fluid administration on rates of postoperative pancreatic leak and delayed gastric emptying.
What is the current status of trial NCT03699917?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2015-01-01. Estimated completion is 2016-07-31.
Who is sponsoring clinical trial NCT03699917?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.